Login to Your Account



Never Too Late?

Fragile X Can Be Reversed by Glutamate Receptor Blocker

By Anette Breindl
Science Editor

Thursday, April 12, 2012
By treating mice with an inhibitor of one type of glutamate receptor, scientists from Roche AG have been able to reverse most symptoms of Fragile X disease in young adult animals. The findings add to the evidence that Fragile X, like a number of other neurodevelopmental disorders, remains treatable even after symptoms have developed.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription